GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, sales@genprice.com
Index / GenWay / Heterogeneous nuclear ribonucleoprotein K - hnRNP K; Transformation up-regulated nuclear protein; TUNP Polyclonal / Product Detail : 18-003-43580 Heterogeneous nuclear ribonucleoprotein K - hnRNP K; Transformation up-regulated nuclear protein; TUNP Polyclonal
Related keywords:
Feb
20th
#18-003-43580 Heterogeneous nuclear ribonucleoprotein K - hnRNP K; Transformation up-regulated nuclear protein; TUNP Polyclonal
Price : | 496 | EUR |
563 | USD | |
385 | GBP | |
2085 | Zloty | |
66416 | JPY | |
3828 | NOK | |
4101 | SEK | |
561 | CHF |
Product name : Heterogeneous nuclear ribonucleoprotein K - hnRNP K; Transformation up-regulated nuclear protein; TUNP Polyclonal
Catalog number : 18-003-43580
Quantity: 0.05 mg Aff Pur
Availability: Yes
Supplier name : GenWay
Data sheet: Ask more or other datasheet now !
Contact us about this product :
Our team will respond you as soon as possible !
We have also other products like : Heterogeneous nuclear ribonucleoprotein K - hnRNP K; Transformation up-regulated nuclear protein; TUNP Polyclonal
other names
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur
GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur
Gentaurpub
Pathways :
WP1502: Mitochondrial biogenesis
WP1068: Nuclear Receptors
WP1099: Nuclear receptors in lipid metabolism and toxicity
WP1184: Nuclear Receptors
WP1326: Nuclear receptors in lipid metabolism and toxicity
WP1385: Nuclear Receptors
WP139: Nuclear receptors in lipid metabolism and toxicity
WP170: Nuclear Receptors
WP1845: MAPK targets/ Nuclear events mediated by MAP kinases
WP217: Nuclear Receptors
WP299: Nuclear receptors in lipid metabolism and toxicity
WP431: Nuclear receptors in lipid metabolism and toxicity
WP509: Nuclear Receptors
WP755: Nuclear receptors in lipid metabolism and toxicity
WP831: Nuclear Receptors
WP863: Nuclear receptors in lipid metabolism and toxicity
WP950: Nuclear Receptors
WP981: Nuclear receptors in lipid metabolism and toxicity
WP1049: G Protein Signaling Pathways
WP1059: Diurnally regulated genes with circadian orthologs
WP1165: G Protein Signaling Pathways
WP1175: Diurnally regulated genes with circadian orthologs
WP1268: Diurnally regulated genes with circadian orthologs
WP1306: Diurnally regulated genes with circadian orthologs
WP1371: G Protein Signaling Pathways
Related Genes :
Bibliography :
[30771276] Regulation and related mechanism of GSN mRNA level by hnRNPK in lung adenocarcinoma cells.
[30658384] New Insights into the Interplay between Non-Coding RNAs and RNA-Binding Protein HnRNPK in Regulating Cellular Functions.
[30599408] Syntheses and evaluation of new Quinoline derivatives for inhibition of hnRNP K in regulating oncogene c-myc transcription.
[30572391] [Effect of hnRNP K and its interaction with HPV16 on cervical intraepithelial neoplasia].
[30476680] Characterization of acute myeloid leukemia with del(9q) - Impact of the genes in the minimally deleted region.
[30450874] Expression analysis of multifunctional RNA-binding protein hnRNP K during development of mammalian testis.
[30444036] O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.
[30397178] Long Noncoding RNA Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2.
[30372559] LncRNA-OG Promotes the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Under the Regulation of hnRNPK.
[30272263] Expression levels of hnRNP K and p21WAF1/CIP1 are associated with resistance to radiochemotherapy independent of p53 pathway activation in rectal adenocarcinoma.
Enter catalog number :
Favorites Pages:
No Favorits